Purification and detailed study of two clinically different human glucose 6-phosphate dehydrogenase variants, G6PDPlymouth and G6PDMahidol: Evidence for defective protein folding as the basis of disease
- 31 January 2008
- journal article
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 93 (1), 44-53
- https://doi.org/10.1016/j.ymgme.2007.08.122
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Functional properties of two mutants of human glucose 6-phosphate dehydrogenase, R393G and R393H, corresponding to the clinical variants G6PD Wisconsin and NashvilleBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
- G6PD Viangchan (871G>A) is the most common G6PD-deficient variant in the Cambodian populationJournal of Human Genetics, 2005
- Two novel variants of human medium chain acyl‐CoA dehydrogenase (MCAD)The FEBS Journal, 2005
- Marked decrease in specific activity contributes to disease phenotype in two human glucose 6-phosphate dehydrogenase mutants, G6PDUnionand G6PDAndalusHuman Mutation, 2005
- Protein Misfolding, Aggregation, and Degradation in DiseaseMolecular Biotechnology, 2005
- HowPAH gene mutations cause hyper-phenylalaninemia and why mechanism matters: Insights from in vitro expressionHuman Mutation, 2003
- G6PDdb, an integrated database of glucose-6-phosphate dehydrogenase (G6PD) mutationsHuman Mutation, 2002
- Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP + molecule and provides insights into enzyme deficiencyStructure, 2000
- G6PD deficiencyBlood, 1994
- G6PD Mahidol, a common deficient variant in South East Asia is caused by a (163)g;ycine - serine mutationNucleic Acids Research, 1989